Lilazel Trademark Details

This mark is dead with a status of Abandoned - No Statement of Use Filed. The last case file activity for this mark occured 19 years ago on Sunday, August 29, 2004, according to the United State Patent & Trademark Office
Word Mark Lilazel
Status Dead 606 — Abandoned - No Statement of Use Filed

Current Owner

Bristol-Myers Squibb Pharma Company of Wilmington, DE

View all trademarks for Bristol-Myers Squibb Pharma Company
Other Trademarks for Bristol-Myers Squibb Pharma Company

Previous Owners

Dupont Pharmaceuticals Company of Wilmington, DE

View all trademarks for Dupont Pharmaceuticals Company
Other Trademarks for Dupont Pharmaceuticals Company
Serial Number 76130046
Status Date Sunday, August 29, 2004
Filing Date Sunday, August 29, 2004
Attorney G Mathew Lombard

Correspondent

G. MATHEW LOMBARD
BRISTOL-MYERS SQUIBB COMPANY
345 PARK AVENUE
NEW YORK NY 10154

Case File Statements

Goods & Services Pharmaceutical Preparations, for the Treatment of Cardiovascular Diseases, Central Nervous System Diseases, Cancer, Inflammation and Inflammatory Diseases, Respiratory and Infectious Diseases and for Diagnostic Imaging

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 006, 018, 044, 046, 051, 052
Status 6 — Active
Status Date Monday, September 25, 2000
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.